Vanda Pharmaceuticals Community

Key Takeaways Expansion of new product launches and increased sales efforts are driving strong growth in psychiatric and neurological treatment markets globally. Advancing a diverse pipeline in CNS and rare diseases reduces reliance on older products and supports long-term profitability through market exclusivity and improved margins.